Stay updated on Risankizumab vs Placebo in Psoriasis in Russia Clinical Trial

Sign up to get notified when there's something new on the Risankizumab vs Placebo in Psoriasis in Russia Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Risankizumab vs Placebo in Psoriasis in Russia Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    A banner announcing NIH terminology changes and linking to transition updates and FAQs is no longer displayed.
    Difference
    1%
    Check dated 2026-11-08T12:52:12.000Z thumbnail image
  2. Check
    14 days ago
    Change Detected
    Summary
    The footer revision changes from v3.7.2 to v3.8.0, while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-01T13:24:50.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    An NIH announcement banner describes a transition from the term “Artificial Intelligence” to “Super Intelligence” across NIH content. The study record itself remains inaccessible behind a 403 error.
    Difference
    1%
    Check dated 2026-10-25T13:11:44.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    The site footer revision changed from v3.7.1 to v3.7.2, while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-18T14:51:58.000Z thumbnail image
  5. Check
    35 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov error page displays an updated site revision number, from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-11T14:34:09.000Z thumbnail image
  6. Check
    55 days ago
    Change Detected
    Summary
    The study record page now displays a 403 Forbidden error, indicating access to the content is blocked. The visible portion shows the site chrome (header/footer) while the actual study details are not accessible.
    Difference
    17%
    Check dated 2026-09-20T22:22:02.000Z thumbnail image

Stay in the know with updates to Risankizumab vs Placebo in Psoriasis in Russia Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Risankizumab vs Placebo in Psoriasis in Russia Clinical Trial page.